|本期目录/Table of Contents|

[1]乔名坤,崔 超.结核性脓胸发生的危险因素分析[J].天津医科大学学报,2019,25(05):493-495.
 QIAO Ming-kun,CUI Chao.Analysis on risk factors for tuberculous empyema[J].Journal of Tianjin Medical University,2019,25(05):493-495.
点击复制

结核性脓胸发生的危险因素分析(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
25
期数:
2019年05期
页码:
493-495
栏目:
临床医学
出版日期:
2019-09-20

文章信息/Info

Title:
Analysis on risk factors for tuberculous empyema
文章编号:
1006-8147(2019)05-0493-03
作者:
乔名坤崔 超
(天津市海河医院胸外科,天津300350)
Author(s):
QIAO Ming-kun CUI Chao
(Department of Thoracic Surgery, Haihe Hospital, Tianjin 300350, China)
关键词:
结核脓胸危险因素
Keywords:
tuberculosis empyema risk factors
分类号:
R655.2
DOI:
-
文献标志码:
A
摘要:
目的:分析结核性脓胸发生的相关危险因素。方法:对2016年8月-2018年8月住院的结核性脓胸患者60例和同期结核性胸膜炎的患者77例进行比较。对患者的性别、糖尿病、引流是否充分、引流是否及时、抗结核治疗情况、是否使用尿激酶、营养风险评分、是否合并肺结核等相关因素进行单因素和多因素分析。结果:单因素分析结果显示,引流是否充分、引流是否及时、是否规律抗结核治疗、耐药、是否使用尿激酶是结核性脓胸发生的危险因素,两组患者相比差异有统计学意义(P<0.05)。多因素Logistic回归分析显示引流是否充分、引流是否及时、是否规律抗结核治疗、耐药、是否使用尿激酶是结核性脓胸发生的危险因素,而患者的性别、糖尿病、营养风险评分、是否合并肺结核不是结核性脓胸的独立危险因素(P>0.05)。结论:结核性脓胸发生的原因是多方面的,为避免结核性脓胸的发生要进行早期整体综合干预。
Abstract:
Objective: To analyze correlative factors for tuberculous empyema in order to reduce occurrence of the disease. Methods: The date from 60 tuberculous empyema and 77 Tuberculous pleurisy, who were admitted from August 2016 to August 2018, were investigated. Several factors including gender, diabetes, adequate drainage, drainage in time, anti tuberculosis therapy, urokinase, nutritional risk score and pulmonary tuberculosis were analyzed by univariate and multivariate analysis. Results: By using single factor analysis, several factors had a significant difference between two groups, including adequate drainage, drainage in time, regular anti tuberculosis, drug resistance and urokinase(P<0.05). Gender, diabetes mellitus,nutritional risk score and pulmonary tuberculosis were not independent risk factors for tuberculous empyema(P>0.05). Multivariate logistic regression analysis further confirmed that adequacy of drainage, timely drainage, regular anti-tuberculosis treatment, drug resistance and use of urokinase were risk factors for tuberculous empyema. Conclusion: The causes of tuberculous empyema are various. In order to avoid the occurrence of tuberculous empyema, early comprehensive intervention should be carried out.

参考文献/References:

[1] 龙建军,周建林,杨秀华,等. 胸腔镜治疗结核性包裹性脓胸患者感染的分析[J].中华医院感染杂志,2016,26(6):1328
[2] 王成,金峰,张运曾.慢性结核性脓胸461例外科治疗回顾性分析[J]. 中华外科杂志,2015,53(8):608
[3] 刘风林.结核性脓胸病理分期对治疗方式选择的指导意义[A].中国防痨协会.2007年中国防痨协会全国学术会议论文集[C].北京:中国防痨协会,2007:1
[4] 艾成.纤维板剥脱术治疗结核性胸膜炎的疗效探讨[J].实用心脑肺血管杂志,2014,22(2):105
[5] 许英.中心静脉导管引流并胸腔内注射尿激酶治疗结核性胸膜炎62例分析[J].临床肺科杂志,2012,17(5):931
[6] 王建东,姚长锦,姚上华,等.胸腔引流治疗结核性胸膜炎的疗效观察[J].吉林医学,2013,34(29):6005
[7] 杨梅,严晓峰.两种方法治疗有分隔的结核性胸膜炎的疗效比较[J].临床肺科杂志,2013,18(2):361
[8] 中华医学会结核病学分会.肺结核诊断和治疗指南(2001年修订)[J].中华结核和呼吸杂志,2001,24(2):17
[9] 中国防痨协会.耐药结核病化学治疗指南[J]. 中华结核和呼吸杂志,2001,33(7):485
[10] Lee B H, Yoon S H, Yeo H J, et al. Impact of Implementation of an Automated Liquid Culture System on Diagnosis of Tuberculous Pleurisy[J]. J Korean Med Sci, 2015, 30(7):871
[11] 闫迪,马卫霞,姜淑娟,等.胸腔镜治疗联合尿激酶局部应用在急性包裹性胸腔积液中的疗效评价[J].山东大学学报(医学版),2016,54(11):32
[12] 马义梅,兰秋艳,骆玲,等. 地塞米松联合尿激酶治疗结核性胸膜炎的临床疗效评价.[J].实用心脑肺血管病杂志,2018,26(z1):36
[13] 聂琦,陶立轩,袁冶,等.尿激酶胸腔内注射治疗结核性脓胸的疗效观察[J].药物与临床,2015,18(11):1918

相似文献/References:

备注/Memo

备注/Memo:
作者简介 乔名坤(1985-),男,住院医师,硕士,研究方向:胸外科及结核外科;通信作者:崔超,E-mail: 18920180116@189.cn。
更新日期/Last Update: 2019-10-11